A specialty Pharmaceutical / Biotechnology company specializing in first in class and best in class topical drug delivery systems. Primary focus is on the discovery, development, and commercialization of products for the topical treatment of inflammatory and infectious diseases. To date, their drug discovery and development efforts have generated a robust product pipeline, including one New Drug Application {"NDA") and two others in Phase II clinical trials. They have another product in late pre-clinical development targeting actinic keratosis and have formulated numerous product candidates targeting digital ulcers, plaque psoriasis, "age-spots", excessive hair growth and skin infections utilizing a proprietary topical drug delivery technology.